Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
US Army
Cantor Fitzgerald
Moodys
Covington
Daiichi Sankyo
US Department of Justice
QuintilesIMS
Argus Health

Generated: April 23, 2018

DrugPatentWatch Database Preview

SEROQUEL Drug Profile

« Back to Dashboard

Which patents cover Seroquel, and what generic alternatives are available?

Seroquel is a drug marketed by Astrazeneca Pharms and Astrazeneca and is included in two NDAs.

The generic ingredient in SEROQUEL is quetiapine fumarate. There are fifty-two drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the quetiapine fumarate profile page.
Drug patent expirations by year for SEROQUEL
Pharmacology for SEROQUEL
Medical Subject Heading (MeSH) Categories for SEROQUEL
Synonyms for SEROQUEL
(E)-2-(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethanol
11-[4-[2-(2-Hydroxyethoxy)ethyl]-1-piperazinyl]dibenzo[b,f][1,4]thiazepine
111974-69-7
111974-72-2
2-(2-(4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethan-1-ol
2-(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethanol
2-(2-(4-Dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)ethanol
2-(2-(4-dibenzo[b,f]-[1,4]thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol
2-(2-(4-dibenzo[b,f][1,4] thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol
2-[2-(4-{2-thia-9-azatricyclo[9.4.0.0;{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-10-yl}piperazin-1-yl)ethoxy]ethan-1-ol
2-[2-(4-benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)ethoxy]ethanol
2-[2-(4-benzo[b][1,5]benzothiazepin-6-ylpiperazin-1-yl)ethoxy]ethanol
2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol
2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-1-yl)ethoxy]ethanol
2-{[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-1-yl)ethyl]oxy}ethanol
2-{2-[4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl]ethoxy}ethanol
4769-EP2272537A2
4769-EP2272841A1
4769-EP2275420A1
4769-EP2298731A1
4769-EP2301936A1
4769-EP2308867A2
4769-EP2308870A2
74Q697
AB00640033_11
AB00640033_12
AB00640033-09
AB00640033-10
AC1L1JE6
AK116453
AKOS003588973
AN-12155
AN-16952
API0004010
BBL029071
BC219347
BDBM50095890
BGL0JSY5SI
BIDD:GT0279
C07397
C21H25N3O2S
CAS-111974-69-7
CCG-213347
CHEBI:8707
CHEMBL716
Co-Quetiapine
CS-1171
CTK8F1296
D08456
D0F9KL
D0H7KF
DB01224
DR002184
DSSTox_CID_3546
DSSTox_GSID_23546
DSSTox_RID_77073
DTXSID9023546
ETH065
Ethanol, 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)-
Ethanol, 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]-
FT-0658790
GTPL50
HMS2093K06
HMS2231O11
HMS3372B05
HSDB 7557
HY-14544
I06-1980
InChI=1/C21H25N3O2S/c25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21/h1-8,25H,9-16H2
KB-80284
Ketipinor (TN)
L001200
LP067777
LS-172170
M872
MFCD00866699
MLS001165710
MLS001195658
MolPort-002-506-329
MRF-0000010
NCGC00095911-01
NCGC00095911-03
NCGC00095911-04
NCGC00095911-06
Norsic
Norsic (TN)
NSC-758918
NSC758918
PD-172760
Pharmakon1600-01505187
quetiapina
quetiapine
Quetiapine (INN)
Quetiapine [INN:BAN]
Quetiapine fumarate
quetiapinum
RT-015180
SBI-0206776.P001
SC-19077
SCHEMBL7932
Seroquel (Fumarate)
Seroquel (TN)
Seroquel XR
SMR000550491
SPECTRUM1505187
STL373578
Tox21_111537
Tox21_111537_1
UNII-BGL0JSY5SI
URKOMYMAXPYINW-UHFFFAOYSA-
URKOMYMAXPYINW-UHFFFAOYSA-N
W-5151
ZD5077
ZINC19632628
ZM 204,636

US Patents and Regulatory Information for SEROQUEL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca Pharms SEROQUEL quetiapine fumarate TABLET;ORAL 020639-001 Sep 26, 1997 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Astrazeneca Pharms SEROQUEL quetiapine fumarate TABLET;ORAL 020639-006 Oct 4, 2005 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Astrazeneca Pharms SEROQUEL quetiapine fumarate TABLET;ORAL 020639-004 Dec 20, 1998 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Astrazeneca SEROQUEL XR quetiapine fumarate TABLET, EXTENDED RELEASE;ORAL 022047-004 May 17, 2007 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for SEROQUEL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca Pharms SEROQUEL quetiapine fumarate TABLET;ORAL 020639-006 Oct 4, 2005 ➤ Try a Free Trial ➤ Try a Free Trial
Astrazeneca Pharms SEROQUEL quetiapine fumarate TABLET;ORAL 020639-002 Sep 26, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Astrazeneca Pharms SEROQUEL quetiapine fumarate TABLET;ORAL 020639-004 Dec 20, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Astrazeneca Pharms SEROQUEL quetiapine fumarate TABLET;ORAL 020639-001 Sep 26, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for SEROQUEL
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Extended-release Tablets 150 mg ➤ Subscribe 2008-11-17
➤ Subscribe Extended-release Tablets 50 mg ➤ Subscribe 2008-10-17
➤ Subscribe Extended-release Tablets 400 mg ➤ Subscribe 2008-06-18
➤ Subscribe Tablets 200 mg and 300 mg ➤ Subscribe 2008-06-12
➤ Subscribe Tablets 50 mg, 150 mg and 400 mg ➤ Subscribe 2007-02-12
➤ Subscribe Tablets 100 mg, 200 mg and 300 mg ➤ Subscribe 2006-02-21
➤ Subscribe Tablets 25 mg ➤ Subscribe 2005-08-12

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Covington
Julphar
Healthtrust
Argus Health
Fish and Richardson
Boehringer Ingelheim
Johnson and Johnson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.